CD244 represents a new therapeutic target in head and neck squamous cell carcinoma

BACKGROUND: Developing novel strategies to overcome the immunosuppressive tumor microenvironment is a critically important area of cancer therapy research. Here, we assess the therapeutic potential of CD244 (2B4/signaling lymphocyte activation molecule family 4), an immunoregulatory receptor found o...

Descripción completa

Detalles Bibliográficos
Autores principales: Agresta, Laura, Lehn, Maria, Lampe, Kristin, Cantrell, Rachel, Hennies, Cassandra, Szabo, Sara, Wise-Draper, Trisha, Conforti, Laura, Hoebe, Kasper, Janssen, Edith M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174077/
https://www.ncbi.nlm.nih.gov/pubmed/32217758
http://dx.doi.org/10.1136/jitc-2019-000245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174077/
https://www.ncbi.nlm.nih.gov/pubmed/32217758
http://dx.doi.org/10.1136/jitc-2019-000245

Ejemplares similares